SCHEMBL7913368

SCHEMBL7913368

CCCCc1ccc(Nc2nnc(-c3ccc(OC)cc3)c3ccccc23)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.68
LMNA P02545 2/20 0.68
ALDH1A1 P00352 2/20 0.67
L3MBTL1 Q9Y468 2/20 0.67
THRB P10828 1/20 0.67
HTT P42858 1/20 0.67
KDR P35968 5/20 0.62
ENPP3 O14638 2/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
TP53 P04637 2/20 0.55
GAA P10253 3/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
NPSR1 Q6W5P4 1/20 0.52
KDM4E B2RXH2 1/20 0.52
USP2 O75604 1/20 0.52
POLB P06746 1/20 0.52
PPARG P37231 1/20 0.52
RECQL P46063 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915171 0.88 NPSR1 (0.61) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL7914864 0.88 NPSR1 (0.61) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL7913341 0.87 NPSR1 (0.67) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL7915141 0.84 MAPT (0.50) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL28681902 0.83 HPGD (0.56) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL3021512 0.83 MAPT (0.81) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL7918628 0.83 MAPT (0.81) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL28682662 0.83 HPGD (0.55) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL15783190 0.81 KDR (0.70) MAPTLMNAALDH1A1L3MBTL1THRB
SCHEMBL3024303 0.81 MAPT (1.00) MAPTLMNAALDH1A1L3MBTL1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed